Evidence map›Paper›PMID 35198458›Full record

ArticleFrontiers in cellular and infection microbiology2022

Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.

Fumitaka Sato, Yumina Nakamura, Aoshi Katsuki, Sundar Khadka, Ijaz Ahmad, Seiichi Omura, Nicholas E Martinez, Ikuo Tsunoda

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Safety ofViruses · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Synthesis of immunomodulatory biomimetic lipid polymer hybrid nanoparticles and application of zebrafish larvae in immunomodulation screening.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Fumitaka SatoDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Yumina NakamuraDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Aoshi KatsukiDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Sundar KhadkaDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Ijaz AhmadDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Seiichi OmuraDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Nicholas E MartinezDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health-Shreveport, Shreveport, LA, United States.
Ikuo TsunodaDepartment of Microbiology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Kindai University · JPLouisiana State University Health Sciences Center Shreveport · US

Funding

COBRE Center for Molecular and Tumor VirologyP30GM110703 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI SAPP, MARTIN · 2014 to 2018
$4.8M
NIGMS NIH HHS P30 GM110703
6 · The paper itself

Abstract

Multiple sclerosis (MS) is an immune-mediated disease characterized by inflammatory demyelination and axonal degeneration in the central nervous system (CNS). Bacterial and fungal infections have been associated with the development of MS; microbial components that are present in several microbes could contribute to MS pathogenesis. Among such components, curdlan is a microbial 1,3-β-glucan that can stimulate dendritic cells, and enhances T helper (Th) 17 responses. We determined whether curdlan administration could affect two animal models for MS: an autoimmune model, experimental autoimmune encephalomyelitis (EAE), and a viral model, Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease (TMEV-IDD). We induced relapsing-remitting EAE by sensitizing SJL/J mice with the myelin proteolipid protein (PLP)

Indexed as

beta-GlucansMultiple SclerosisTheilovirusAnimalsDisease Models, AnimalMicebeta-Glucanscurdlananimal modelsbioinformaticsCNS demyelinating diseasesfungal infectionsneuropathologypersistent virus infectionsPicornaviridae infectionsprincipal component analysis

Identifiers

PMID35198458
PMCPMC8859099
OpenAlexW4210467357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.